Rapid
Therapeutic Science Laboratories, Inc. (OTC: RTSL) manufactures and markets
FDA-listed pressurized metered dose inhalers (pMDIs) that enable users to
conveniently and safely self-administer CBD.
RTSL's MDIs deliver a 98% bioavailable dose of CBD each & every time and
could very well replace vape pens, tanks and mods and have a major impact on a
$9 Billion market.